Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Receivables - Net: 2011-2024

Historic Receivables - Net for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $7.8 million.

  • Niagen Bioscience's Receivables - Net rose 19.87% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 19.87%. This contributed to the annual value of $7.8 million for FY2024, which is 48.41% up from last year.
  • Niagen Bioscience's Receivables - Net amounted to $7.8 million in FY2024, which was up 48.41% from $5.2 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Receivables - Net ranged from a high of $8.5 million in FY2022 and a low of $2.7 million during FY2020.
  • In the last 3 years, Niagen Bioscience's Receivables - Net had a median value of $7.8 million in 2024 and averaged $7.2 million.
  • In the last 5 years, Niagen Bioscience's Receivables - Net surged by 93.99% in 2021 and then crashed by 38.29% in 2023.
  • Niagen Bioscience's Receivables - Net (Yearly) stood at $2.7 million in 2020, then spiked by 93.99% to $5.2 million in 2021, then soared by 62.30% to $8.5 million in 2022, then plummeted by 38.29% to $5.2 million in 2023, then surged by 48.41% to $7.8 million in 2024.